| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03287778 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2020-04-01 | |
| P921 | main subject | physiological effect of drugs | Q50379782 |
| P4135 | maximum age | 80 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 50 | |
| P4844 | research intervention | vitamin B | Q183206 |
| pyridoxine | Q423746 | ||
| pyridoxal | Q3065731 | ||
| P6153 | research site | University of North Carolina at Chapel Hill | Q192334 |
| P859 | sponsor | University of North Carolina at Chapel Hill | Q192334 |
| P580 | start time | 2017-12-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia |
Search more.